Title: Sandra E. Dunn: Innovator in Breast Cancer Treatment
Introduction
Sandra E. Dunn is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of cancer treatment, particularly focusing on innovative methods for addressing triple negative breast cancer. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Sandra E. Dunn holds a patent titled "Methods Of Inhibiting Rsk For Treatment Of Breast Cancer." This patent outlines a method of treating triple negative breast cancer by administering an effective dose of an inhibitor against the p90 ribosomal S6 kinase (RSK) family of kinases. The method may involve selective inhibition of RSK1 or RSK2, utilizing inhibitors such as siRNA, BI-D1870, or SL0101. Although she currently has 0 patents, her research is pivotal in the ongoing fight against breast cancer.
Career Highlights
Sandra is associated with Phoenix Molecular Designs, where she applies her expertise in molecular biology and oncology. Her role at the company allows her to collaborate with other talented professionals in the field, contributing to groundbreaking research and development.
Collaborations
Some of her notable coworkers include Anna Stratford and Kristen Reipas. Their collective efforts enhance the research environment at Phoenix Molecular Designs, fostering innovation and collaboration in cancer treatment.
Conclusion
Sandra E. Dunn is a dedicated inventor whose work in breast cancer treatment exemplifies the importance of innovation in medicine. Her contributions, particularly in the development of methods to inhibit RSK, are vital for advancing therapeutic options for patients.